ANGELA SCHAPKER: Open Payments
NPI 1174777072 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 67 payments from 20 companies in 2025. Trend: 2023 $2,648 · 2024 $1,460 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $385 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Eisai Inc. | 2 | $84 |
| Lilly USA, LLC | 3 | $46 |
| Lundbeck LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
Products named: UBRELVY, REXULTI, QULIPTA, Leqembi, Auvelity, VRAYLAR, MOUNJARO, GEMTESA.
Industry payments across IN — which companies pay providers there.
